Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15.03. | Spotlight Stock Market: Market Notice 51/24- Last day of trading in Medimi AB's subscription option TO 7 | 1 | Cision News | ||
20.12.23 | Spotlight Stock Market: Market Notice 274/23 - Last day of trading in Medimi AB's BTA | 3 | Cision News | ||
17.11.23 | XFRA CAPITAL ADJUSTMENT INFORMATION - 17.11.2023 | 470 | Xetra Newsboard | Das Instrument MKL NO0004822503 ATEA ASA NK 1 EQUITY wird cum Kapitalmassnahme gehandelt am 17.11.2023 und ex Kapitalmassnahme am 20.11.2023 The instrument MKL NO0004822503 ATEA ASA NK 1 EQUITY is traded... ► Artikel lesen | |
15.11.23 | Spotlight Stock Market: Market Notice 248/23 - Information regarding the rights issue from Medimi AB | 2 | Cision News |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PROCEPT BIOROBOTICS | 52,28 | -0,38 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
PROGYNY | 32,500 | 0,00 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
RXSIGHT | 51,89 | -1,80 % | RxSight, Inc. - 8-K, Current Report | ||
PRIVIA HEALTH GROUP | 17,990 | -0,99 % | Where Privia Health Gr Stands With Analysts | ||
MIMEDX | 6,245 | 0,00 % | Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers | ||
MOBILE-HEALTH NETWORK SOLUTIONS | 23,780 | 0,00 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
FRESENIUS | 27,200 | +0,07 % | Fresenius: Aktie knackt Hürde - wichtige Termine voraus | Die Aktie von Fresenius kommt immer mehr in Fahrt. Am heutigen Montag gewinnt das Papier weitere 1,2 Prozent auf 27,21 Euro, nachdem Fresenius in den vergangenen Wochen bereits deutlich zulegen konnte.... ► Artikel lesen | |
IMAC HOLDINGS | 5,100 | 0,00 % | (BACK) - Analyzing IMAC Holdings' Short Interest | ||
ATRICURE | 22,610 | -1,91 % | AtriCure upgraded at Oppenheimer on valuation | ||
ADAPTHEALTH | 9,580 | 0,00 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 10,410 | -3,43 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Announces Recent Acquisitions That Continue to Drive Growth and Value | LOUISVILLE, Ky., March 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or "BrightSpring Health Services") (NASDAQ: BTSG), a leading provider of home and community-based... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 52,42 | +0,23 % | DAX im Minus, Nahost-Lage spitzt sich zu: Rheinmetall, Lufthansa, Siemens Healthineers, TUI ... | Nachdem der DAX am Donnerstag noch freundlich mit einem Plus von 0,4 Prozent auf 17.837,40 Zählern aus dem Handel gegangen war, zeichnet sich für den letzten Handelstag der Woche ein kräftiges Minus... ► Artikel lesen | |
EUROPEAN WAX CENTER | 11,510 | -0,69 % | European Wax Center, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results | Fiscal Year 2023 versus 2022 Net new centers increased 10.6% to 1,044 total centers in 45 statesSystem-wide sales of $955.0 million increased 6.3%Total revenue of $221.0 million increased 6.6%Same-store... ► Artikel lesen | |
TREACE MEDICAL CONCEPTS | 10,300 | -3,47 % | Treace Medical Concepts, Inc.: Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance | PONTE VEDRA, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical... ► Artikel lesen | |
ACLARION | 0,393 | 0,00 % | Aclarion, Inc.: Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain |